Transgene Revenue and Competitors
Estimated Revenue & Valuation
- Transgene's estimated annual revenue is currently $39.7M per year.
- Transgene's estimated revenue per employee is $189,856
Employee Data
- Transgene has 209 Employees.
- Transgene grew their employee count by 0% last year.
Transgene's People
Name | Title | Email/Phone |
---|---|---|
1 | Chairman and CEO | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | Investor Relations Analyst & Financial Communications Officer - Dir.Fi. | Reveal Email/Phone |
4 | Head Oncolytic Virus Laboratory | Reveal Email/Phone |
5 | Head Protein science lab | Reveal Email/Phone |
6 | Vp operations pharmaceutiques et pharmacien responsable | Reveal Email/Phone |
7 | Head Vectorology Laboratory | Reveal Email/Phone |
8 | Head Biometry (Biostatistics, Data Management) | Reveal Email/Phone |
9 | EVP, General Counsel & Corporate Secretary | Reveal Email/Phone |
10 | Associate Medical Director | Reveal Email/Phone |
Transgene Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 15 | -32% | N/A | N/A |
#10 | $10.1M | 48 | -9% | N/A | N/A |
What Is Transgene?
Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer.
keywords:N/AN/A
Total Funding
209
Number of Employees
$39.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Transgene News
2022-04-17 - Feral alfalfa populations are sustaining and growing | Hay and ...
These populations can act as a reservoir for GM transgenes and aid in gene ... respectively, contained the transgene in 2011 and 2012.
2022-03-30 - Transgene: Availability of Preparatory Documents for the ...
With Transgene's myvac® platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully...
2022-03-22 - Transgene's Board of Directors Strengthens Its Governance ...
Transgene's Board of Directors Strengthens Its Governance and Proposes the Appointment of Dr. Alessandro Riva as Independent Chairman. The roles...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $54.4M | 218 | -6% | N/A |
#2 | $45M | 224 | 2% | N/A |
#3 | $45.9M | 296 | 2% | N/A |